Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -4,156.20%-43.63K | -84.88%-61.49K | 72.89%-16.29K | -59.65%-103.12K | 77.62%-8.75K | 96.28%-1.03K | 12.44%-33.26K | -250.26%-60.09K | 68.05%-64.59K | 64.63%-39.08K |
| Net income from continuing operations | 662.11%273.8K | 18.97%-28.18K | 23.23%-49.13K | -3,014.66%-4.01M | -3,132.63%-3.95M | 50.49%35.93K | -512.69%-34.77K | -64.33%-64K | -161.12%-128.81K | -976.01%-122.17K |
| Depreciation and amortization | --0 | --0 | --0 | -10.28%515 | -40.28%86 | 1.40%145 | -2.08%141 | 0.00%143 | 33.80%574 | 0.00%144 |
| Asset impairment expenditure | ---- | ---- | ---- | 13,262.94%3.95M | --3.95M | ---- | ---- | ---- | 0.00%-30K | ---- |
| Remuneration paid in stock | ---- | ---- | ---- | -93.60%5.44K | ---- | ---- | ---- | ---- | --84.98K | ---- |
| Remuneration paid in stock | -71.46%2.09K | --0 | -89.10%1.89K | -35.59%34.61K | -104.60%-1.39K | -33.91%7.32K | 128.26%11.34K | 130.97%17.33K | 2.64%53.73K | 106.56%30.18K |
| Deferred tax | --0 | --0 | --0 | 48.43%-66.34K | 71.41%-6.04K | 16.32%-54.1K | 78.95%-4.28K | 91.45%-1.93K | 65.65%-128.66K | 71.86%-21.12K |
| Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | -75.63%-2.58K | 56.35%-2.71K | 7.89%-2.65K | -176.34%-1.68K |
| Change In working capital | -892.18%-34.75K | -971.47%-33.31K | 446.51%30.95K | -116.36%-14.11K | 31.42%-6.46K | 193.70%4.39K | -1,282.13%-3.11K | -108.93%-8.93K | 248.03%86.24K | 85.80%-9.42K |
| -Change in receivables | 41.42%-12.44K | 33.59%871 | -71.08%1.2K | -92.03%6.28K | 213.15%22.73K | -61.93%-21.24K | -82.98%652 | -94.87%4.15K | 191.59%78.81K | 176.16%7.26K |
| -Change in prepaid assets | -29.57%605 | -10.14%638 | -66.95%632 | 166.81%1.73K | -2,295.00%-1.76K | -41.37%859 | -72.10%710 | 128.66%1.91K | -3,297.37%-2.58K | -96.79%80 |
| -Change in payables and accrued expense | -192.49%-22.91K | -678.82%-34.82K | 294.26%29.12K | -320.90%-22.12K | -63.70%-27.43K | 255.29%24.77K | 26.86%-4.47K | -157.85%-14.99K | -64.06%10.01K | 71.75%-16.75K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -4,156.20%-43.63K | -84.88%-61.49K | 72.89%-16.29K | -59.65%-103.12K | 77.62%-8.75K | 96.28%-1.03K | 12.44%-33.26K | -250.26%-60.09K | 68.05%-64.59K | 64.63%-39.08K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -93.06%8.63K | -168.51%-22.77K | -76.08%11.84K | -2.27%98.25K | -543.06%-108.87K | 189.35%124.4K | -87.19%33.23K | 211.74%49.48K | 105.92%100.52K | 105.49%24.57K |
| Net PPE purchase and sale | 107.25%8.63K | -190.64%-22.77K | 221.64%11.84K | 65.36%-212.44K | 34.97%-108.86K | 26.40%-118.97K | 126.12%25.12K | 94.82%-9.73K | 58.23%-613.23K | 83.54%-167.4K |
| Net investment purchase and sale | --0 | --0 | --0 | -48.30%310.69K | -100.00%-2 | 2,086.77%243.36K | -96.82%8.11K | -58.80%59.21K | 180.69%600.97K | 299.63%213.98K |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -78.16%112.78K | ---22.01K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -93.06%8.63K | -168.51%-22.77K | -76.08%11.84K | -2.27%98.25K | -543.06%-108.87K | 189.35%124.4K | -87.19%33.23K | 211.74%49.48K | 105.92%100.52K | 105.49%24.57K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 151.82K | 12.5K | 0 | 0 | 0 | 0 | 0 | -106.17%-37.2K | -113.01%-79.48K |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---40K | ---- |
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | --0 | --12.5K | --0 | --0 | --0 | --0 | --0 | --7.5K | --0 |
| Net other financing activities | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 90.00%-4.7K | -1.23%-39.48K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --151.82K | --12.5K | --0 | --0 | --0 | --0 | --0 | -106.17%-37.2K | -113.01%-79.48K |
| Net cash flow | ||||||||||
| Beginning cash position | 162.08%131.58K | 27.44%64.01K | -8.02%55.97K | -2.04%60.84K | 12.11%173.58K | -82.20%50.21K | -17.14%50.23K | -2.04%60.84K | -95.43%62.11K | 1,657.25%154.83K |
| Current changes in cash | -128.37%-35K | 270,372.00%67.57K | 175.85%8.05K | -284.48%-4.88K | -25.14%-117.61K | 196.93%123.37K | -100.01%-25 | -612.21%-10.61K | 99.90%-1.27K | -276.33%-93.99K |
| End cash Position | -44.36%96.59K | 162.08%131.58K | 27.44%64.01K | -8.02%55.97K | -8.02%55.97K | 12.11%173.58K | -82.20%50.21K | -17.14%50.23K | -2.04%60.84K | -2.04%60.84K |
| Free cash from | -46.27%-153K | -207.82%-72.42K | 76.67%-16.29K | 54.91%-315.56K | 48.53%-117.61K | 37.43%-104.6K | 82.46%-23.53K | 58.93%-69.83K | 58.10%-699.83K | 79.74%-228.49K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.